AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27059387 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol I and II
Number of subjects: 33
Study 24670467 — intervention group
Group type: EXPERIMENTAL
Intervention: Drained blood reinfusion (group A)
Number of subjects: 98
Study 24670467 — intervention group
Group type: COMPARATOR
Intervention: No drained blood reinfusion (group B)
Number of subjects: 98
Study 23148715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed (group-individual) modality intervention incorporating Motivational Interviewing, Dialectical Behavior Therapy skills, and job-related skills.
Number of subjects: 174
Study 23148715 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 174
Study 21068707 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual hyperinflation (MH)
Number of subjects: 74
Study 18054379 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantics decision task with early delivery of the go signal
Number of subjects: 0
Study 18054379 — intervention group
Group type: COMPARATOR
Intervention: Semantics decision task with delayed delivery of the go signal
Number of subjects: 0
Study 18054379 — intervention group
Group type: EXPERIMENTAL
Intervention: Lexical decision task with early delivery of the go signal
Number of subjects: 0
Study 16545641 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (5 microg/min)
Number of subjects: 81
Study 16545641 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (5 microg/min)
Number of subjects: 81
Study 16545641 — intervention group
Group type: EXPERIMENTAL
Intervention: CIMT measurement
Number of subjects: 81
Study 12861468 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol adjustable dosing (n = 69)
Number of subjects: 127
Study 12861468 — intervention group
Group type: COMPARATOR
Intervention: Budesonide/formoterol fixed dosing (n = 58)
Number of subjects: 127
Study 12861468 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol adjustable dosing
Number of subjects: 127
Study 12861468 — intervention group
Group type: COMPARATOR
Intervention: Budesonide/formoterol fixed dosing
Number of subjects: 127
Study 10733048 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalent vertebral deformities
Number of subjects: 6459
Study 8801736 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (irradiation of the remaining breast tissue)
Number of subjects: 278
Study 8801736 — intervention group
Group type: COMPARATOR
Intervention: Control group (no postoperative radiotherapy)
Number of subjects: 278
Study 8801736 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 278
Study 1281081 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantified EEG frequency analysis (EEGFA)
Number of subjects: 25
Study 1281081 — intervention group
Group type: COMPARATOR
Intervention: Conventional EEG
Number of subjects: 25
Study 1281081 — intervention group
Group type: EXPERIMENTAL
Intervention: EEGFA
Number of subjects: 25
Study 1281081 — intervention group
Group type: EXPERIMENTAL
Intervention: EEGFA and Conventional EEG
Number of subjects: 25
Study 6715084 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% solution of lignocaine iontophoresed for 10 min at 1‐2.5 mA
Number of subjects: 0
Study 6715084 — intervention group
Group type: COMPARATOR
Intervention: Placebo iontophoresis
Number of subjects: 0
Study 31216875 — intervention group
Group type: EXPERIMENTAL
Intervention: GCSWLI
Number of subjects: 50
Study 31216875 — intervention group
Group type: COMPARATOR
Intervention: WLC
Number of subjects: 50
Study 29956503 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit formation-enhanced group-based DPP
Number of subjects: 208
Study 29956503 — intervention group
Group type: COMPARATOR
Intervention: Standard group-based DPP
Number of subjects: 208
Study 27097959 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 107
Study 27097959 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 107
Study 25138574 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1,000 mg daily
Number of subjects: 84
Study 25138574 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone 30 mg daily
Number of subjects: 84
Study 22142309 — intervention group
Group type: COMPARATOR
Intervention: PKEK treatment
Number of subjects: 76
Study 22142309 — intervention group
Group type: COMPARATOR
Intervention: PKEK combined with sodium ascorbyl phosphate (SAP)
Number of subjects: 76
Study 22142309 — intervention group
Group type: COMPARATOR
Intervention: PKEK added to SAP-containing preparation
Number of subjects: 76
Study 22142309 — intervention group
Group type: COMPARATOR
Intervention: PKEK+SAP formulation
Number of subjects: 76
Study 20684789 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise intervention
Number of subjects: 660
Study 20684789 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical activity and counseling
Number of subjects: 660
Study 20684789 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies defining a step goal
Number of subjects: 660
Study 17979862 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity-individualized (HI) training group
Number of subjects: 30
Study 17979862 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-intensity-generalized (LG) training group
Number of subjects: 30
Study 17979862 — intervention group
Group type: COMPARATOR
Intervention: Control (C) group (no treadmill training)
Number of subjects: 30
Study 17979862 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (HI, LG, C)
Number of subjects: 30
Study 15731535 — intervention group
Group type: COMPARATOR
Intervention: Myocardial perfusion alone
Number of subjects: 143
Study 15731535 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined wall motion analysis with myocardial perfusion
Number of subjects: 143
Study 12196649 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial magnetic stimulation (TMS)
Number of subjects: 24
Study 12196649 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (placebo)
Number of subjects: 24
Study 9825232 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan (group A)
Number of subjects: 41
Study 9825232 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 41
Study 7666093 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus AS101
Number of subjects: 44
Study 7666093 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 44
Study 2495983 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate 50 mg
Number of subjects: 16
Study 2495983 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate 100 mg
Number of subjects: 16
Study 2495983 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate 150 mg
Number of subjects: 16
Study 2495983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 919799 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular Arteparon forte injections and physical therapy (group 1)
Number of subjects: 115
Study 919799 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy only (group 2)
Number of subjects: 115
Study 31511399 — intervention group
Group type: EXPERIMENTAL
Intervention: Water treadmill (WT) conditioning for 18 days
Number of subjects: 9
Study 31511399 — intervention group
Group type: COMPARATOR
Intervention: Dry treadmill (DT) control
Number of subjects: 9
Study 31025878 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin patch
Number of subjects: 278
Study 31025878 — intervention group
Group type: COMPARATOR
Intervention: Insulin pen
Number of subjects: 278
Study 28588322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus gemcitabine (G)
Number of subjects: 49
Study 28588322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus gemcitabine and nab-paclitaxel (G+NP)
Number of subjects: 49
Study 28588322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus gemcitabine and vinorelbine (G+V)
Number of subjects: 49
Study 28588322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus irinotecan (I)
Number of subjects: 49
Study 28588322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus liposomal doxorubicin (LD)
Number of subjects: 49
Study 28588322 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 49
Study 28588322 — intervention group
Group type: COMPARATOR
Intervention: Immunotherapy alone
Number of subjects: 49
Study 25733162 — intervention group
Group type: EXPERIMENTAL
Intervention: mLSG15 plus mogamulizumab
Number of subjects: 53
Study 25733162 — intervention group
Group type: COMPARATOR
Intervention: mLSG15 alone
Number of subjects: 53
Study 23561229 — intervention group
Group type: EXPERIMENTAL
Intervention: levomilnacipran SR 40 mg
Number of subjects: 724
Study 23561229 — intervention group
Group type: EXPERIMENTAL
Intervention: levomilnacipran SR 80 mg
Number of subjects: 724
Study 23561229 — intervention group
Group type: EXPERIMENTAL
Intervention: levomilnacipran SR 120 mg
Number of subjects: 724
Study 23561229 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 724
Study 21964877 — intervention group
Group type: EXPERIMENTAL
Intervention: Astaxanthin
Number of subjects: 27
Study 21964877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 19327999 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized muscle fatigue
Number of subjects: 20
Study 19327999 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body fatigue
Number of subjects: 20
Study 19327999 — intervention group
Group type: COMPARATOR
Intervention: Control (seated position for 5 min)
Number of subjects: 20
Study 16704567 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg)
Number of subjects: 24
Study 16704567 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 24
Study 14514977 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐gamma 0.1 mg/m2 weekly (arm A)
Number of subjects: 95
Study 14514977 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐gamma 0.3 mg/m2 iv daily x 5 every 3 weeks plus IFN‐alpha 10 MU/m2 daily (arm B)
Number of subjects: 95
Study 14514977 — intervention group
Group type: COMPARATOR
Intervention: IFN‐gamma alone
Number of subjects: 95
Study 11051055 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride administration
Number of subjects: 0
Study 8956931 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-made modular diet (MD)
Number of subjects: 18
Study 8956931 — intervention group
Group type: COMPARATOR
Intervention: Semi-elemental formula (SF)
Number of subjects: 18
Study 1539732 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐8 infusion
Number of subjects: 17
Study 1539732 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 17
Study 3963030 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen (73 patients) administered two, three, or four times a day in total daily doses of 100, 150, or 200 mg
Number of subjects: 147
Study 3963030 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (74 patients) administered two, three, or four times a day in total daily doses of 2,000, 3,000, or 4,000 mg
Number of subjects: 147
Study 31299774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridge-split technique with horizontal augmentation using autogenous bone graft
Number of subjects: 14
Study 31299774 — intervention group
Group type: COMPARATOR
Intervention: Ridge-split method with simultaneous implant placement
Number of subjects: 14
Study 28298182 — intervention group
Group type: EXPERIMENTAL
Intervention: new electrocardiogram
Number of subjects: 65
Study 28298182 — intervention group
Group type: COMPARATOR
Intervention: conventional electrocardiogram
Number of subjects: 65
Study 25577190 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT for psychosis (CBTp)
Number of subjects: 113
Study 25577190 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 113
Study 24078500 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular diclofenac sodium (1 mg/kg) 45 minutes before the procedure
Number of subjects: 105
Study 24078500 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (10 gm) applied locally 45 minutes before the procedure
Number of subjects: 105
Study 24078500 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac diethylamine gel (15 gm) applied locally 45 minutes before the procedure
Number of subjects: 105
Study 24078500 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 105
Study 21808866 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioguided occult lesion localization (ROLL)
Number of subjects: 108
Study 21808866 — intervention group
Group type: COMPARATOR
Intervention: Wire-guided localization
Number of subjects: 108
Study 18330545 — intervention group
Group type: EXPERIMENTAL
Intervention: Current opioid users
Number of subjects: 63
Study 18330545 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinent opioid users
Number of subjects: 63
Study 18330545 — intervention group
Group type: COMPARATOR
Intervention: Healthy participants
Number of subjects: 63
Study 16469456 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin prophylaxis
Number of subjects: 428
Study 16469456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 428
Study 12616584 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Disorder Inventory (EDI‐2) assessment in infertile patients
Number of subjects: 120
Study 12616584 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 120
Study 12616584 — intervention group
Group type: COMPARATOR
Intervention: Comparison with fertile women
Number of subjects: 120
Study 12616584 — intervention group
Group type: COMPARATOR
Intervention: Comparison with patients suffering from anorexia nervosa (AN‐R)
Number of subjects: 120
Study 11781629 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 g/day of eicosapentaenoic acid (EPA) orally from 3 weeks before to about 180 days after transplantation
Number of subjects: 16
Study 11781629 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 16
Study 11781629 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 g/day of eicosapentaenoic acid (EPA)
Number of subjects: 16
Study 9260858 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 10
Study 9260858 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 10
Study 7923485 — intervention group
Group type: EXPERIMENTAL
Intervention: Incontinent patients with rectal prolapse
Number of subjects: 31
Study 7923485 — intervention group
Group type: COMPARATOR
Intervention: Continent patients with rectal prolapse
Number of subjects: 31
Study 3619975 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 14
Study 3619975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 29705992 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotics
Number of subjects: 25
Study 29705992 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics followed by oral antibiotics
Number of subjects: 25
Study 27344435 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon-expandable cobalt-chromium SCUBA™ stent
Number of subjects: 280
Study 27344435 — intervention group
Group type: COMPARATOR
Intervention: Self-expanding COMPLETE-SE™ nitinol stent
Number of subjects: 280
Study 22672673 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted sled (WS) training
Number of subjects: 22
Study 22672673 — intervention group
Group type: COMPARATOR
Intervention: Unresisted (UR) training
Number of subjects: 22
Study 22672673 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study 23464594 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 269
Study 23464594 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 269
Study 23464594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 21569168 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) biomarker panel assessment (CK-MB, myoglobin, and troponin, measured at baseline and 90 minutes)
Number of subjects: 2243
Study 21569168 — intervention group
Group type: COMPARATOR
Intervention: Standard care without the POC panel
Number of subjects: 2243
Study 21569168 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) biomarker panel assessment
Number of subjects: 2243
Study 21569168 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 2243
Study 21569168 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) panel
Number of subjects: 2243
Study 19103332 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload meal constituted 1/2 portion of pasta
Number of subjects: 33
Study 19103332 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload meal constituted 1 portion of pasta
Number of subjects: 33
Study 19103332 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload meal constituted 1 1/2 portions of pasta
Number of subjects: 33
Study 19103332 — intervention group
Group type: EXPERIMENTAL
Intervention: Portion size information
Number of subjects: 33
Study 17057294 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins and dietary supplements (vit. E, beta-carotene, acetylsalicylic acid) in combination with treatment measures
Number of subjects: 0
Study 17057294 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopplerometric research
Number of subjects: 0
Study 12696990 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat, 120 mg three times daily
Number of subjects: 0
Study 12696990 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetes therapy and weight management alone (Control)
Number of subjects: 0
Study 10702450 — intervention group
Group type: COMPARATOR
Intervention: Epidural droperidol 0.0 mg
Number of subjects: 140
Study 10702450 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural droperidol 1.25 mg
Number of subjects: 140
Study 10702450 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural droperidol 2.5 mg
Number of subjects: 140
Study 10702450 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural droperidol 5.0 mg
Number of subjects: 140
Study 9080303 — intervention group
Group type: EXPERIMENTAL
Intervention: cM-T412 (chimeric CD4 monoclonal antibody)
Number of subjects: 0
Study 7677972 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention (LBWE) - seven hospital sessions and four home sessions with a nurse
Number of subjects: 24
Study 7677972 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention (LBWE)
Number of subjects: 24
Study 7677972 — intervention group
Group type: COMPARATOR
Intervention: Control group (LBWC)
Number of subjects: 24
Study 7677972 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal birth weight children
Number of subjects: 24
Study 3812881 — intervention group
Group type: EXPERIMENTAL
Intervention: HDCSV intramuscularly at two sites on days 0 and 3
Number of subjects: 118
Study 3812881 — intervention group
Group type: COMPARATOR
Intervention: Conventional single-site intramuscular regimen
Number of subjects: 118
Study 3812881 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 ml doses of diploid cell vaccine given subcutaneously at eight sites
Number of subjects: 118
Study 3812881 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard single-site diploid cell vaccine
Number of subjects: 118
Study 3812881 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-site intradermal regimen of diploid cell vaccine
Number of subjects: 118
Study 30400892 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid toothbrush (Elgydium Clinic/Inava Hybrid) used in combined mode
Number of subjects: 66
Study 30400892 — intervention group
Group type: COMPARATOR
Intervention: Oscillating-rotating toothbrush (Oral-B Vitality)
Number of subjects: 66
Study 30400892 — intervention group
Group type: EXPERIMENTAL
Intervention: Both toothbrushes
Number of subjects: 66
Study 26987887 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-based quadrivalent virus-like particle (QVLP) vaccine
Number of subjects: 0
Study 26987887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24957311 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive impairment assessment using MMSE-M and TICS-M scales
Number of subjects: 1572
Study 24957311 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive impairment related to increasing age, stroke severity, heart rate, and cerebral atrophy
Number of subjects: 1572
Study 24957311 — intervention group
Group type: EXPERIMENTAL
Intervention: TICS-M related to dependency (modified Rankin Scale)
Number of subjects: 1572
Study 24957311 — intervention group
Group type: EXPERIMENTAL
Intervention: TICS-M related to disability (Barthel Index)
Number of subjects: 1572
Study 24957311 — intervention group
Group type: EXPERIMENTAL
Intervention: TICS-M related to mood (Zung Depression Score)
Number of subjects: 1572
Study 24957311 — intervention group
Group type: EXPERIMENTAL
Intervention: TICS-M related to quality of life (Euro Quality of life-5 Descriptor)
Number of subjects: 1572
Study 22912868 — intervention group
Group type: EXPERIMENTAL
Intervention: Clostridium Histolyticum collagenase (CHC)
Number of subjects: 12
Study 19890274 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin-alfa treatment with high hemoglobin target (13.5 g/l)
Number of subjects: 0
Study 19890274 — intervention group
Group type: COMPARATOR
Intervention: Epoetin-alfa treatment with low hemoglobin target (11.3 g/l)
Number of subjects: 0
Study 18772726 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (0.2 mg/kg; maximum 15 mg)
Number of subjects: 107
Study 18772726 — intervention group
Group type: COMPARATOR
Intervention: Codeine (2 mg/kg; maximum 120 mg)
Number of subjects: 107
Study 18772726 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 107
Study 18772726 — intervention group
Group type: COMPARATOR
Intervention: Codeine
Number of subjects: 107
Study 20655807 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC units stored for 10 days or fewer
Number of subjects: 1434
Study 20655807 — intervention group
Group type: COMPARATOR
Intervention: RBC units stored for 21 days or more
Number of subjects: 1434
Study 15627208 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm cranking at 60% of peak oxygen uptake (AC(60))
Number of subjects: 8